Anaemia is a common complication in chronic kidney disease (CKD) patients. It has a complicated pathophysiology and its management is equally challenging. It is mainly due to impaired erythropoiesis, decreased production of erythropoietin and dysregulated iron metabolism. The pri...
Open access
Research Article10.9734/ajmah/2025/v23i51236
The global burden of Chronic Kidney Disease (CKD) is increasing with estimates suggesting that up to 10% of the world’s population is affected. Anxiety and depression are the most commonly reported mental health conditions associated with CKD especially those on hemodialysis. So...
Open access
Research Article10.9734/ajmah/2025/v23i41203
Objective and Background: The prevalence of type 2 diabetes mellitus (T2DM) is steadily increasing globally. A significant complication of T2DM is diabetic kidney disease, which contributes to increased morbidity and mortality. Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitors...
Open access
Research Article10.9734/ajmah/2024/v22i121139
Background: Morbidity and mortality envisaged by chronic kidney disease (CKD) remains a health menace throughout the world. Complications, incidence, prevalence, the impact of dietary recommendations, risk factors, outcome, and management strategies have not been rationalized due...
Open access
Research Article10.9734/ajmah/2021/v19i1030387
Introduction: Chronic kidney disease (CKD) has become a global public health threat. The irreversible nature of the disease, its association with significant morbidity and mortality as well as the cost of renal replacement therapy leads to a large burden for health care providers...
Open access
Research Article10.9734/AJMAH/2017/36085